These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10506614)

  • 1. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration.
    Jhaveri FM; Klein EA; Kupelian PA; Zippe C; Levin HS
    J Clin Oncol; 1999 Oct; 17(10):3167-72. PubMed ID: 10506614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing trends in pathological stage migration in radical prostatectomy specimens.
    Derweesh IH; Kupelian PA; Zippe C; Levin HS; Brainard J; Magi-Galluzzi C; Myles J; Reuther AM; Klein EA
    Urol Oncol; 2004; 22(4):300-6. PubMed ID: 15283887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A; Tareen B; Lepor H
    Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive posterior margin of needle biopsy cores is an independent predictor for extracapsular extension in retropubic radical prostatectomy.
    Yamanaka H; Matsumoto K; Obata J; Ninomiya A; Mukai K; Nakamura S
    Urology; 2013 May; 81(5):986-9. PubMed ID: 23490520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
    Chun FK; Briganti A; Gallina A; Hutterer GC; Shariat SF; Antebie E; Walz J; Roehrborn CG; Salonia A; Rigatti P; Saad F; Huland H; Montorsi F; Graefen M; Karakiewicz PI
    Eur Urol; 2007 Oct; 52(4):1067-74. PubMed ID: 17383807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer.
    Roach M; Chen A; Song J; Diaz A; Presti J; Carroll P
    Semin Urol Oncol; 2000 May; 18(2):108-14. PubMed ID: 10875450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
    J Clin Oncol; 1996 Jun; 14(6):1770-7. PubMed ID: 8656245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study.
    Gilliland FD; Hoffman RM; Hamilton A; Albertsen P; Eley JW; Harlan L; Stanford JL; Hunt WC; Potosky A; Stephenson RA
    J Urol; 1999 Oct; 162(4):1341-5. PubMed ID: 10492193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens.
    Satake N; Ohori M; Yu C; Kattan MW; Ohno Y; Miyakawa A; Hatano T; Tachibana M
    Int J Urol; 2010 Mar; 17(3):267-72. PubMed ID: 20132361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice.
    Amling CL; Blute ML; Lerner SE; Bergstralh EJ; Bostwick DG; Zincke H
    Mayo Clin Proc; 1998 May; 73(5):401-6. PubMed ID: 9581578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy.
    Cookson MS; Fleshner NE; Soloway SM; Fair WR
    Urology; 1997 Jun; 49(6):887-93. PubMed ID: 9187696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml.
    Masieri L; Minervini A; Vittori G; Lanciotti M; Lanzi F; Lapini A; Carini M; Serni S
    Int Urol Nephrol; 2012 Aug; 44(4):1031-8. PubMed ID: 22315156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
    Ohori M; Kattan MW; Koh H; Maru N; Slawin KM; Shariat S; Muramoto M; Reuter VE; Wheeler TM; Scardino PT
    J Urol; 2004 May; 171(5):1844-9; discussion 1849. PubMed ID: 15076291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
    Epstein JI; Walsh PC; Carmichael M; Brendler CB
    JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can preoperative prostate MRI before radical prostatectomy predict extracapsular extension and the side of the index lesion?].
    Albisinni S; De Groote A; Deneft F; Thoma P; Catteau X; Roumeguère T; Wildschutz T
    Prog Urol; 2016 Apr; 26(5):281-6. PubMed ID: 26996453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.